Reagent kit for quantitative determination of glycated hemoglobin A1c content in whole blood by immunoturbidimetric method "GLYCOHEMOGLOBIN ABRIS+" according to TU 21.20.23-113-27428909-2024 In versions: Configuration No1, consisting of: - reagent 1 -1 vial. (30 ml); - reagent 2 - 1 vial. (10 ml); - Reagent 3 (lysis reagent) - 1 fl. (100 ml); - instructions for use; -passport. Configuration No2, consisting of: - reagent 1 -1 vial. (45 ml); - reagent 2 - 1 vial. (15 ml); - reagent 3 (lysis reagent) - 2 vials. (100 ml); - instructions for use; -passport. Configuration No3, consisting of: - reagent 1 - 2 vials. (43.5 ml each); - reagent 2 - 2 vials. (14.5 ml); - Reagent 3 (lysis reagent) - 4 vials. (100 ml); - instructions for use; -passport. Configuration No4, consisting of: - reagent 1 - 4 vials. (15 ml); - reagent 2 - 4 vials. (5 ml each); - Reagent 3 (lysis reagent) - 3 vials. (100 ml); - instructions for use; -passport. - Roszdravnadzor Registration РЗН 2024/23684

Access comprehensive regulatory information for Reagent kit for quantitative determination of glycated hemoglobin A1c content in whole blood by immunoturbidimetric method "GLYCOHEMOGLOBIN ABRIS+" according to TU 21.20.23-113-27428909-2024 In versions: Configuration No1, consisting of: - reagent 1 -1 vial. (30 ml); - reagent 2 - 1 vial. (10 ml); - Reagent 3 (lysis reagent) - 1 fl. (100 ml); - instructions for use; -passport. Configuration No2, consisting of: - reagent 1 -1 vial. (45 ml); - reagent 2 - 1 vial. (15 ml); - reagent 3 (lysis reagent) - 2 vials. (100 ml); - instructions for use; -passport. Configuration No3, consisting of: - reagent 1 - 2 vials. (43.5 ml each); - reagent 2 - 2 vials. (14.5 ml); - Reagent 3 (lysis reagent) - 4 vials. (100 ml); - instructions for use; -passport. Configuration No4, consisting of: - reagent 1 - 4 vials. (15 ml); - reagent 2 - 4 vials. (5 ml each); - Reagent 3 (lysis reagent) - 3 vials. (100 ml); - instructions for use; -passport. in the Russia medical device market through Pure Global AI's free database. This Class 2a medical device is registered under Roszdravnadzor registration number РЗН 2024/23684 and manufactured by NPF ABRIS+ LLC. The device was registered on September 23, 2024.

This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.